---
figid: PMC8195970__40618_2020_1445_Fig1_HTML
figtitle: 'TSH lowering effects of metformin: a possible mechanism of action'
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8195970
filename: 40618_2020_1445_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8195970/figure/Fig1/
number: F1
caption: Proposed signaling pathway linking the Insulin receptor substrate 1 to thyroid
  stimulating hormone. Panel A. Thyroid stimulating hormone (TSH) by triggering its
  receptor (TSHR) increases intracellular cyclic adenosine monophosphate (cAMP) levels
  that, in turn, activates protein kinase A (PKA). Activated PKA phosphorylates the
  protein phosphatase 1β (PP1β), which modify the phosphorylation of specific domains
  of insulin receptor substrate 1 (IRS1), thus activating the phosphatidylinositol-3
  kinase (PI3K)/protein kinase B (AKT) pathway. Panel B In patients with insulin-resistance,
  the abnormal pattern of IRS1 phosphorylation hinders the signaling pathway, partially
  interfering with the activation of the PI3K/AKT cascade
papertitle: 'TSH lowering effects of metformin: a possible mechanism of action.'
reftext: R. Cannarella, et al. J Endocrinol Invest. 2021;44(7):1547-1550.
year: '2021'
doi: 10.1007/s40618-020-01445-9
journal_title: Journal of Endocrinological Investigation
journal_nlm_ta: J Endocrinol Invest
publisher_name: Springer International Publishing
keywords: TSH | Metformin | Hypothyroidism | Insulin-resistance | Thyroid | Insulin
automl_pathway: 0.8758563
figid_alias: PMC8195970__F1
figtype: Figure
redirect_from: /figures/PMC8195970__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8195970__40618_2020_1445_Fig1_HTML.html
  '@type': Dataset
  description: Proposed signaling pathway linking the Insulin receptor substrate 1
    to thyroid stimulating hormone. Panel A. Thyroid stimulating hormone (TSH) by
    triggering its receptor (TSHR) increases intracellular cyclic adenosine monophosphate
    (cAMP) levels that, in turn, activates protein kinase A (PKA). Activated PKA phosphorylates
    the protein phosphatase 1β (PP1β), which modify the phosphorylation of specific
    domains of insulin receptor substrate 1 (IRS1), thus activating the phosphatidylinositol-3
    kinase (PI3K)/protein kinase B (AKT) pathway. Panel B In patients with insulin-resistance,
    the abnormal pattern of IRS1 phosphorylation hinders the signaling pathway, partially
    interfering with the activation of the PI3K/AKT cascade
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tshr
  - Ppp1cc
  - Npy4r
  - Akt1
  - Popdc3
  - Pik3r1
  - Cnot7
  - Popdc2
  - Igf1
  - Tnfrsf11b
  - Txnrd1
  - Tas1r1
  - Tmeff1
  - Ptpn11
  - ras
  - Hras
  - Kras
  - Rem1
  - Mdk
  - Ephb2
  - Mapk1
  - Igf2
  - D7Zem1
  - D7Zem3
  - D7Zem2
  - Raf1
  - TSHR
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PPA1
  - NPY4R
  - NPY4R2
  - AKT1
  - AKT2
  - AKT3
  - POPDC3
  - MLST8
  - PYDC5
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CNOT8
  - POPDC2
  - PYDC2
  - IGF1
  - TNFRSF11B
  - TXNRD1
  - TMEFF1
  - TAS1R1
  - MSANTD3-TMEFF1
  - PTPN11
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - IGF2
  - RAF1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Pp1alpha-96A
  - flw
  - br
  - Pp4-19C
  - Pp1-13C
  - Pp1-87B
  - PpD6
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pop2
  - csw
  - Sos
  - grb
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - MKP-4
  - p38b
---
